Who we are
Medicines for Europe
Purpose and Objectives
OUR VALUES
STRUCTURE
OUR MEMBERS
BECOME A MEMBER
CODE OF CONDUCT
DISCLOSURE
JOB OPPORTUNITIES
Key topics
Access
INDUSTRIAL POLICY
REGULATORY AND LEGAL FRAMEWORK
FALSIFIED MEDICINES
ENVIRONMENT
ANTIMICROBIAL RESISTANCE
MEDICINE SHORTAGES
Publications
Factsheets
Infographics
Reports
Policy
Videos
Newsroom
Press releases
In the news
Press kit
Contact us
Login
Generic medicines
Home
Who we are
Generic medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
Definition
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Biosimilar medicines
Home
Who we are
Biosimilar medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
DEFINITION
THERAPEUTIC AREAS
GLOSSARY
Q&A
What’s new
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
External resources
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Related links
Contact us
Twitter
Value added medicines
Home
Who we are
Value added medicines Group
MISSION AND VISION
STRUCTURE
MEMBERS
BECOME A MEMBER
Did you know?
PAYER PERCEPTIONS AND ASSESSMENT
Definition
THERAPEUTIC AREAS
Q&A
What’s new
PAYER PERCEPTIONS AND ASSESSMENT
Value Added Medicines award 2018
FACTSHEETS
POLICY
REPORTS
VIDEOS
INFOGRAPHICS
Our 5 pillars
Patients
QUALITY
VALUE
SUSTAINABILITY
PARTNERSHIP
Find out more
Contact us
Events
Newsroom
Filters:
in-the-news
x
2018
x
News about
By type
In the news
Press releases
By year
2019
2018
2017
2016
2015
2014
Twitter
Tweets
Videos
Photos
SPC manufacturing waiver is good news for Europe
19 September 2018
An SPC manufacturing waiver should be extremely beneficial for Europe […]
Read more
Analysis of the proposal for a regulation of a manufacturing exception related to the SPC and aimed to make the European industry competitive
13 September 2018
Open
Andriukaitis: SPC manufacturing waiver does not damage pharma innovation
12 June 2018
Open
Generics driving pharmerging market growth? ‘There is still opportunity for EU’ says Medicines for Europe
22 May 2018
Open
Up to 25,000 pharma jobs if EU alters patent rules
21 May 2018
Open
Access to Biosimilars in EU Expected to Continue to Outpace US and Canada
26 April 2018
Open
Stakeholders To Gather In London To Plan Biosimilar Market’s Future
17 April 2018
Open
Increasing access to cancer medicines: what role do biosimilar medicines play?
9 April 2018
Open
Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation
30 March 2018
Open
El sistema español podría mejorar su coste-eficiencia con un plan nacional
27 February 2018
Open
Posts navigation
1
2
Subscribe to our newsletter
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok